These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 32206102

  • 21. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee SW, Lee J, Ahn BC.
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [Abstract] [Full Text] [Related]

  • 22. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy.
    Yang L, Han D, Zhan Q, Li X, Shan P, Hu Y, Ding H, Wang Y, Zhang L, Zhang Y, Xue S, Zhao J, Hou X, Wang Y, Li P, Yuan X, Qi H.
    Theranostics; 2019; 9(25):7680-7696. PubMed ID: 31695794
    [Abstract] [Full Text] [Related]

  • 23. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
    Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X, Qian X, Jia H, Zhao J, Sun J, Hou X, Yuan X, Kang C.
    ACS Nano; 2016 Mar 22; 10(3):3323-33. PubMed ID: 26938862
    [Abstract] [Full Text] [Related]

  • 24. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S.
    Pharm Res; 2015 Jun 22; 32(6):2003-14. PubMed ID: 25609010
    [Abstract] [Full Text] [Related]

  • 25. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
    Li M, Wang J, Guo P, Jin L, Tan X, Zhang Z, Zhanghuang C, Mi T, Liu J, Wang Z, Wu X, Wei G, He D.
    Biomater Adv; 2022 Nov 22; 142():213161. PubMed ID: 36308859
    [Abstract] [Full Text] [Related]

  • 26. Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications.
    Ren X, Kang C, Garcia-Contreras L, Kim D.
    Int J Mol Sci; 2023 May 03; 24(9):. PubMed ID: 37175872
    [Abstract] [Full Text] [Related]

  • 27. Exosome mediated communication within the tumor microenvironment.
    Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM.
    J Control Release; 2015 Dec 10; 219():278-294. PubMed ID: 26143224
    [Abstract] [Full Text] [Related]

  • 28. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
    Alibolandi M, Abnous K, Mohammadi M, Hadizadeh F, Sadeghi F, Taghavi S, Jaafari MR, Ramezani M.
    J Control Release; 2017 Oct 28; 264():228-236. PubMed ID: 28844758
    [Abstract] [Full Text] [Related]

  • 29. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
    Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, Huang B, Li L, Tang J, Ju J, Guan H, Song B.
    Cancer Lett; 2019 Sep 10; 459():122-134. PubMed ID: 31173853
    [Abstract] [Full Text] [Related]

  • 30. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer.
    Li YJ, Wu JY, Wang JM, Hu XB, Cai JX, Xiang DX.
    Acta Biomater; 2020 Jan 01; 101():519-530. PubMed ID: 31629893
    [Abstract] [Full Text] [Related]

  • 31. Enhanced Efficacy of Gastric Cancer Treatment through Targeted Exosome Delivery of 17-DMAG Anticancer Agent.
    Park JH, Kim SJ, Kim OH, Kim DJ.
    Int J Mol Sci; 2024 Aug 12; 25(16):. PubMed ID: 39201449
    [Abstract] [Full Text] [Related]

  • 32. Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach.
    Santos A, Domingues C, Jarak I, Veiga F, Figueiras A.
    Eur J Pharm Biopharm; 2022 Jan 12; 170():91-111. PubMed ID: 34896571
    [Abstract] [Full Text] [Related]

  • 33. Function and therapeutic development of exosomes for cancer therapy.
    Kim SB.
    Arch Pharm Res; 2022 May 12; 45(5):295-308. PubMed ID: 35604532
    [Abstract] [Full Text] [Related]

  • 34. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S, Nguyen TDT, Marasini R, Aryal S.
    Acta Biomater; 2019 Aug 12; 94():482-494. PubMed ID: 31129363
    [Abstract] [Full Text] [Related]

  • 35. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.
    Apte A, Koren E, Koshkaryev A, Torchilin VP.
    Cancer Biol Ther; 2014 Jan 12; 15(1):69-80. PubMed ID: 24145298
    [Abstract] [Full Text] [Related]

  • 36. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis.
    Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, Patel GK, Singh AP, Singh S.
    Int J Nanomedicine; 2019 Jan 12; 14():531-541. PubMed ID: 30666112
    [Abstract] [Full Text] [Related]

  • 37. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
    Xue M, Chen W, Xiang A, Wang R, Chen H, Pan J, Pang H, An H, Wang X, Hou H, Li X.
    Mol Cancer; 2017 Aug 25; 16(1):143. PubMed ID: 28841829
    [Abstract] [Full Text] [Related]

  • 38. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
    Yao S, Yin Y, Jin G, Li D, Li M, Hu Y, Feng Y, Liu Y, Bian Z, Wang X, Mao Y, Zhang J, Wu Z, Huang Z.
    Cancer Med; 2020 Aug 25; 9(16):5989-5998. PubMed ID: 32618144
    [Abstract] [Full Text] [Related]

  • 39. A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.
    Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV.
    J Control Release; 2013 May 28; 168(1):61-9. PubMed ID: 23474033
    [Abstract] [Full Text] [Related]

  • 40. Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
    Yamaguchi K, Matsumoto Y, Suzuki R, Nishida H, Omata D, Inaba H, Kukita A, Tanikawa M, Sone K, Oda K, Osuga Y, Maruyama K, Fujii T.
    Cancer Sci; 2021 Jun 28; 112(6):2493-2503. PubMed ID: 33793049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.